Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from EUDA Health Holdings ( (EUDA) ).
On August 1, 2025, EUDA Health Holdings Limited entered into a convertible promissory note purchase agreement with an institutional investor for up to $10 million, with an initial $1 million note purchased. By September 19, 2025, EUDA and the investor agreed to a letter agreement, delivering 41,620 shares at $0.901 per share and pausing further note conversions until December 15, 2025, unless stock prices reach $2.00 for three consecutive days. This agreement impacts EUDA’s financial strategy by managing share conversions and potential stock price fluctuations.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited operates in the healthcare industry, focusing on providing health services and products. The company is based in Singapore and engages in financial agreements to support its operations.
Average Trading Volume: 109,751
Technical Sentiment Signal: Sell
Current Market Cap: $42.36M
For an in-depth examination of EUDA stock, go to TipRanks’ Overview page.